Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
---|---|---|---|---|---|
EP3811943B1 | 22 Feb, 2023 | Compound For Use In The Treatment Of Ocular Disorders | Mar, 2034 | 3 | |
EP3461484B9 | 09 Jun, 2021 | Combination Therapy | Mar, 2034 | 3 |